Global Human Microbiome Market Report 2022: Increased Prevalence of Microbial Dysbiosis Driving Industry Growth –


DUBLIN–(BUSINESS WIRE)–The report “Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027” has been added to from offer.

The global human microbiome market size reached US$558.5 million in 2021. Looking forward, the publisher expects the market to reach US$1,827.2 million by 2027, posting a CAGR of 21.84% in 2021-2027. Bearing in mind the uncertainties associated with COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic. This information is included in the report as a major market contributor.

The human microbiome refers to the genes found inside various microorganisms present in the genetic portrait, or metagenome, of humans. It consists of various microorganisms, such as bacteria, fungi, protozoa, non-living viruses, and many single-celled organisms.

These organisms have an impact on human physiology and contribute to the improvement or alteration of metabolic and immune functions. They are found in human tissues and are studied for medical advances and analytical techniques. Microbiomes are used in probiotics, prebiotics, pharmaceutical drugs, and diagnostic and therapeutic systems for various conditions, such as diabetes, obesity, cancer, and metabolic, gastrointestinal, neurological, central nervous system disorders and autoimmune.

Human Microbiome Market Trends:

The increasing prevalence of lifestyle-related chronic diseases and microbial dysbiosis infections across the globe is one of the major factors driving the market growth. Additionally, the growing geriatric population, which is more susceptible to such conditions, is providing an impetus for the growth of the market. The growth of the market can also be attributed to the growing focus on developing human microbiome therapies with increased efficacy.

For example, human gut microbiomes are developed in specific combinations for the effective treatment of various gastrointestinal conditions. In this light, the outbreak of the coronavirus (COVID-19) pandemic is also providing impetus for the growth of the market. Researchers are studying lung microbiomes in depth to analyze the severity of infections and develop appropriate therapeutics and vaccines.

Moreover, various advancements such as the development of target-specific microbiome-based therapies are also driving the market growth. Other factors including extensive research and development (R&D) activities along with significant growth in the pharmaceutical industry, especially in developing economies, are expected to drive the market towards growth.

Key Market Segmentation:

The publisher provides an analysis of key trends in each sub-segment of the Global Human Microbiome market report, as well as forecasts at the global, regional and country levels from 2022 to 2027. Our report has categorized the market based on product , application and disease type.

Breakdown by product:

  • Probiotics

  • Prebiotics

  • Diagnostic tests

  • Drugs

  • medical food

  • Others

Breakdown by application:

Breakdown by type of disease:

  • Obesity

  • Diabetes

  • Autoimmune disorders

  • Cancer

  • Gastrointestinal problems

  • Central nervous system disorders

  • Others

Breakdown by region:

  • North America

  • United States

  • Canada

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Others

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Russia

  • Others

  • Latin America

  • Brazil

  • Mexico

  • Others

  • Middle East and Africa

Answers to key questions in this report:

  • How has the global human microbiome market performed so far and how will it perform in the coming years?

  • What has been the impact of COVID-19 on the global human microbiome market?

  • What are the main regional markets?

  • What is the market breakdown by product?

  • What is the market breakdown by application?

  • What is the market breakdown by disease type?

  • What are the different stages of the industry value chain?

  • What are the key drivers and challenges in the industry?

  • What is the structure of the global human microbiome market and who are the key players?

  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation

5 Global Human Microbiome Market

6 Market Breakdown by Product

7 Market Breakdown by Application

8 Market Breakdown by Disease Type

9 Market Breakdown by Region

10 SWOT Analysis

11 Value chain analysis

12 Analysis of the five forces of carriers

13 Price Analysis

14 Competitive landscape

Companies cited

  • 4D pharma plc

  • Atlas Biomed Group Limited


  • BiomX

  • Bione

  • DayTwo Inc.


  • Ferring B.V.

  • therapeutic finch

  • Second Genome Inc.

  • SynBioBeta LLC

  • Synthetic Biologics Inc.

  • Vedanta Biosciences Inc.

  • Viome Inc.

For more information about this report visit


Comments are closed.